Lensar (LNSR) Interest Coverage Ratio (2019 - 2020)

Lensar (LNSR) reported Interest Coverage Ratio of 72.49 for Q3 2020, down 571.0% year-over-year from 15.39 in Q4 2019, and down 1165.74% quarter-over-quarter from 5.73 in Q2 2020.

Lensar (LNSR) Interest Coverage Ratio (2019 - 2020) Analysis & Trends

Lensar (LNSR) has 2 years of Interest Coverage Ratio data on file, last reported at 72.49 in Q3 2020.

  • Interest Coverage Ratio for Q3 2020 came in at 72.49, down 571.0% year-over-year; the trailing twelve-month figure through Jun 2021 was 325.15 (down 5215.5% YoY), and the FY2020 annual result was 13.81, down 117.31% from the prior year.
  • Interest Coverage Ratio eased to 72.49 in Q3 2020 per LNSR's latest filing, from 5.73 in the prior quarter.
  • Over five years, Interest Coverage Ratio peaked at 3.49 in Q4 2019 and troughed at 72.49 in Q3 2020.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Interest Cover (Qtr)
1 Abbott Laboratories 154.42 Bn 147.76 Bn 6.27 Bn 7.73
2 Stryker 118.12 Bn 115.25 Bn 3.81 Bn 6.32
3 Medtronic 101.72 Bn 93.55 Bn 5.76 Bn 8.09
4 Boston Scientific 67.19 Bn 65.98 Bn 3.61 Bn 12.23
5 Edwards Lifesciences 50.69 Bn 47.02 Bn 1.29 Bn -
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -2.90
7 Dexcom 28.09 Bn 26.97 Bn 750.30 Mn -
8 GE HealthCare Technologies 28.08 Bn 26.02 Bn 1.98 Bn 5.36
9 Steris 19.80 Bn 19.37 Bn 697.10 Mn 20.98
10 Lensar 70.05 Mn 70.34 Mn 6.38 Mn -

Historic Data

Download Data
DateValue
Sep 30, 2020 -72.49
Jun 30, 2020 -5.73
Mar 31, 2020 -5.13
Dec 31, 2019 -3.49
Sep 30, 2019 -10.80